USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
USANA Health Sciences, Inc.NYSE: USNA
Investing Cash Flow · Q1 FY2026 · quarter ended Apr 2026
Investing cash flow declines year over year
Q1 FY2026 investing cash flow of $2.6M (cash outflow) fell 33.0% year over year, ahead of the -95.8% change in trailing-twelve-month investing cash flow. Over 3 fiscal years it compounded at -6.5% a year.
Context
- Investing cash flow amounted to 1.1% of revenue in FY2025, down 23.8 pp from a year earlier.
- Investing cash flow grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -33.0% holds above the trailing-twelve-month pace of -95.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (10.13M) USD
- Year-over-year change
- +95.2%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | (10.13M) | +95.2% |
| FY2024 | 2024-12-28 | (213.09M) | -1679.5% |
| FY2023 | 2023-12-31 | (11.98M) | +3.2% |
| FY2022 | 2022-12-31 | (12.37M) | +12.8% |
| FY2021 | 2021-12-31 | (14.19M) | — |
Investing Cash Flow vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -95.8% is the 7th highest of 8, against a peer median of +87.8%.
- Investing cash flow amounts to 1.0% of revenue for USNA, versus a peer median of 3.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2025 | CN¥115.68M CNY | -114.6% | — | 0.5% | |
| LTM Mar 2026 | R$93.36M BRL | +87.8% | +5.9% | 17.1% | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | $44.01M USD | -62.6% | +3.5% | 3.4% |
| LTM Mar 2026 | $36.01M USD | +2713.6% | +76.2% | 15.7% | |
| LTM Apr 2026 | $18.6M USD | +314.3% | +158.9% | 9.8% | |
| LTM Apr 2026 | $8.85M USD | -95.8% | -6.5% | 1.0% | |
| LTM Mar 2026 | $1.96M USD | +131.6% | — | 0.5% | |
| LTM Apr 2026 | $1.73M USD | -94.2% | — | 0.1% | |
| Peer median (excluding USNA) | — | +87.8% | +41.1% | 3.4% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 116.51M | 69.35M | 63.79M | 42.06M | 10.76M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 32.56M |
| Deferred Income Tax | (2.97M) | (7.18M) | (2.75M) | (6.74M) | (7.13M) |
| Stock-Based Compensation | 14.3M | 13.49M | 14.6M | 14.56M | 13.83M |
| Change in Working Capital | (28.86M) | 771K | (28M) | (13M) | (43.08M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | (10.5M) | 15.8M | 2.35M | (2.12M) | (34.69M) |
| Accounts Payables | (4.57M) | (2.66M) | (428K) | (1.27M) | 5.2M |
| Other Working Capital | (13.79M) | (12.37M) | (29.92M) | (9.62M) | (13.6M) |
| Other Non-Cash Items | 61K | 6.07M | 2.61M | 1.89M | 15.41M |
| Operating Cash Flow | 121.23M | 103.9M | 70.64M | 60.99M | 22.35M |
| Capital Expenditures | (12.76M) | (10.4M) | (14.49M) | (10.07M) | (13.82M) |
| Acquisitions (Net) | (1.94M) | (6.53M) | 0 | (203.34M) | 0 |
| Purchases of Investments | (1.56M) | 0 | (1.27M) | (870K) | 0 |
| Sales of Investments | 1.94M | 4.56M | 3.78M | 1.13M | 0 |
| Other Investing Activities | 131K | 7K | 15K | 64K | 3.7M |
| Investing Cash Flow | (14.19M) | (12.37M) | (11.98M) | (213.09M) | (10.13M) |
| Debt Repayment | 0 | 0 | 792K | 22.22M | (9M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (177.84M) | (25.38M) | (11.6M) | (9.44M) | (27.51M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.58M) | (4.71M) | (3.43M) | (3.22M) | (4.1M) |
| Financing Cash Flow | (181.41M) | (30.09M) | (14.24M) | 9.55M | (40.6M) |
| Effect of Forex Changes | 2.09M | (13.78M) | (2.5M) | (6.19M) | 5.11M |
| Net Change in Cash | (72.28M) | 47.67M | 41.93M | (148.74M) | (23.27M) |
| Free Cash Flow | 108.46M | 93.5M | 56.15M | 50.92M | 8.53M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.